Cefoxitin interactions
Cefoxitin (Mefoxin), a cephalosporin has 63 documented interactions across the FDA labels and fact sheets we index: 27 major, 35 moderate, 1 minor, and 0 where a label reports no significant interaction. Each entry below quotes the sentence behind it. This drug page is a starting point, not a verdict for your situation.
Interactions from the label
Major interactions (27)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (Ertapenem label, Contraindications)
Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (Imipenem and cilastatin label, Warnings and precautions)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Hypersensitivity to cefoxitin or other beta-lactam antibacterial drugs. (Cefoxitin label, Contraindications)
Moderate interactions (35)
Aminoglycosides: Increased potential of nephrotoxicity. (Cefoxitin label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (Aztreonam label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (Ethacrynic acid label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (Furosemide label, Drug interactions)
Aminoglycosides: Increased potential of nephrotoxicity. (Cefoxitin label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (Mycophenolate label, Drug interactions)
Aminoglycosides: Increased potential of nephrotoxicity. (Cefoxitin label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Aminoglycosides: Increased potential of nephrotoxicity. (Cefoxitin label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
- ProbenecidModerate
Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Probenecid label, Drug interactions)
- Probenecid and colchicineModerate
DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (Probenecid and colchicine label, Drug interactions)
- ProtamineModerate
Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (Protamine label, Precautions)
Aminoglycosides: Increased potential of nephrotoxicity. (Cefoxitin label, Drug interactions)
High concentrations of cefoxitin in the urine may interfere with measurement of urinary 17-hydroxy-corticosteroids by the Porter-Silber reaction, and produce false increases of modest degree in the levels reported. (Cefoxitin label, Warnings and precautions)
Minor mentions (1)
Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (Meropenem label, Warnings and precautions)
Check Cefoxitin against everything you take. Add your full list; every pair is checked at once.
Open in the checkerNot medical advice. Severity reflects the label's wording, not your circumstances. A "major" flag can be routine under supervision and a "minor" one can matter at high doses. Ask a pharmacist.